| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |